CYP2C19 genotype testing to guide clopidogrel use after ischaemic stroke or transient ischaemic attack

Following the committee meeting on 28 September 2023, the External Assessment Group (EAG) have completed further analyses as a result of points raised during the committee discussion. The next steps in the evaluation will be delayed to allow this analysis to be considered. The topic webpage will be updated with the revised timelines in due course.